This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Psychiatry  • Evidence-Based Medicine  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I am writing on behalf of the National Mental Health Association (NMHA) in response to the article titled "Off-label Prescribing Among Office-Based Physicians" by Radley et al.¹

As an organization, NMHA is concerned with the inappropriate prescribing of medications; however, we are also concerned about the potential to conclude from the study by Radley et al,¹ that all off-label prescribing is inappropriate. The study's conclusion that off-label use of medications lacks rigorous scientific scrutiny has strong implications and could lead to a false assumption about the usefulness of off-label prescribing.

While there is a dearth of scientific research on off-label prescribing, off-label treatments can be grounded in top-notch research and have proved to be beneficial for many individuals. At NMHA, we believe that this study does not highlight the positive outcomes that can result from off-label prescribing practices. Through the appropriate use of off-label prescriptions, physicians can successfully determine the . . . [Full Text of this Article]

AUTHOR INFORMATION
Jennifer L. Bright, MPA

RELATED LETTER

Positive Outcomes Through the Appropriate Use of Off-Label Prescribing—Reply
Randall S. Stafford, David C. Radley, and Stan N. Finkelstein
Arch Intern Med. 2006;166(22):2555.
EXTRACT | FULL TEXT